Zofran 4 mg/2 ml

Trade Name:

Zofran 4 mg/2 ml

Solution for Injection or Infusion

Composition

Active ingredient:

Ondansetron (as hydrochloride dihydrate) 2 mg/1 ml

Inactive ingredients: citric acid monohydrate (E330), sodium citrate (E331), sodium chloride and Water for Injections.

Properties

Zofran Solution for Injection or Infusion contains a medicine called ondansetron (as hydrochloride dihydrate). This belongs to a group of medicines called anti-emetics.

Indications

-preventing nausea and vomiting caused by chemotherapy or radiotherapy for cancer

-preventing nausea and vomiting after surgery

Dosage and administration

Chemotherapy and Radiotherapy induced nausea and vomiting (CINV and RINV)

Adults:

The emetogenic potential of cancer treatment varies according to the doses and combinations of chemotherapy and radiotherapy regimens used. The selection of dose regimen should be determined by the severity of the emetogenic challenge.

Side effects

These reactions are rare in people taking Zofran. If you have an allergic reaction, tell your doctor or a member of the medical staff straight away.

The signs may include:

sudden wheezing and chest pain or chest tightness

Contraindications

— taking apomorphine (used to treat Parkinson’s disease)

— allergy (hypersensitivity) to ondansetron or any of the other ingredients in Zofran injection

Warnings and precautions:

Storage

Store at a temperature not exceeding 30°C

Package:

Carton box holds plastic tray of 5 ampoules 2 ml